Healthtech Startups

Athaca provides AI-driven solutions for clinical trial management, including synthetic patient cohort generation for rare diseases, intelligent data quality analysis, and protocol design risk assessment. The platform operates in regulated healthcare environments with emphasis on data privacy, auditability, and compliance.

1 investor

Athel AI builds a multi-agent AI "co-clinician" that conducts dynamic clinical intake interviews with patients by voice, chat, and video, then delivers structured, prioritized clinical summaries to physicians before the visit. It serves physicians and clinics—including primary care, specialist, and telehealth practices—to reduce administrative burden, with a focus on Ontario and the North American (Canada/US) healthcare market.

1 investor

Athena Aesthetics is a platform and partner for aesthetics/medical practices, handling back-office functions such as HR, IT, finance, inventory management, and compliance while providing marketing and expansion support. It offers practice owners cash and equity in exchange for partnering, letting founders continue leading their existing practices with operational backing.

1 investor

Athlete offers life insurance with quarterly cashback tied to a user's fitness level, assessed through the Athlete app. It acts as an introducer to partner advisors and rewards policyholders based on physical activity assessments, operating in the UK.

1 investor

Athletico is a physical therapy provider operating a network of more than 900 clinic locations, offering rehabilitation and related clinical care to patients. It also serves workers' compensation clients and works with third-party payors across its business segments.

1 investor

Athos Medical Technology is a healthcare-focused company founded within the NHS England Clinical Entrepreneur Programme that develops technology to improve patient care and the efficiency of the health system. It is developing medical/pharmaceutical technology with contributions in areas such as drug delivery materials.

1 investor

Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients. The device is investigational and not yet available for sale.

1 investor

Atlas Acupuncture is an acupuncture and Chinese herbal medicine practice serving the greater Burlington community. The practice provides integrative healthcare focused on treating underlying imbalances to support long-term health improvement.

1 investor

Atlas Clinical operates as a clinical research site conducting FDA-regulated trials for pharmaceutical and biotechnology sponsors. The company recruits and manages volunteer participants through multi-phase in-human testing of new drug candidates and therapeutic devices.

1 investor

AtlasDiscovery develops foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design and success rates. The company serves pharmaceutical and biotech firms by predicting human drug responses and enabling drug rescue and development in the biotech industry.

1 investor

Atlas Urology is a urology medical practice providing patient care for conditions such as UTIs, kidney stones, and infections. The practice is led by Dr. Bryan Allen and is based in Bradenton, Florida.

1 investor

Atlas5D develops motion-sensing technology to monitor health and wellbeing for elderly adults, assisted living facilities, and clinical trial participants. The system tracks movement patterns and behavioral changes to enable early intervention and support informed healthcare decisions.

1 investor

Atlas Endoscopy develops a robotic colonoscopy system for clinical use in diagnostic and therapeutic procedures. The company targets healthcare systems and endoscopists seeking to improve patient outcomes and increase procedural capacity.

1 investor

Atlas HP develops and manages ambulatory surgical center (ASC) networks for nonprofit health systems and physicians through joint venture partnerships. The company provides strategy, operations, and infrastructure to help health systems scale surgical capacity and create revenue diversification.

1 investor

AtlasXomics develops spatial epigenomics tools, spanning chip fabrication, hardware, and bioinformatics, for researchers studying areas such as cancer and systems biology. The company serves scientific and clinical research customers with technology for analyzing epigenetic regulation.

1 investor

Atman Labs develops an AI reasoning system that combines knowledge graphs and reinforcement learning to emulate expert decision-making under uncertainty, with an initial focus on AI-powered clinical diagnostics and primary care consultation.

1 investor

Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.

1 investor

AtomVie is a contract development and manufacturing organization (CDMO) that provides cGMP manufacturing and global distribution of radiopharmaceuticals for diagnostic and therapeutic applications. The company serves clinical developers and commercial manufacturers advancing drugs through development toward commercialization.

1 investor

Atransen Pharma is a biotech company developing novel cancer treatments through LAT1 inhibitors and transporter-based drug discovery approaches. The company's research builds on amino acid transporter science from Osaka University and aims to create more effective cancer therapies with fewer side effects.

1 investor

Atraverse Medical develops flexible transseptal access technologies for left-heart catheter procedures, including an RF-guidewire enabled puncture device that supports a Zero Exchange workflow. Its products are aimed at physicians performing catheter-based cardiac interventions.

1 investor

Atria Health and Research Institute provides personalized preventive medicine and longevity services, combining clinical care with research to demonstrate and advance disease prevention strategies. The institute serves individuals and health professionals seeking to prevent chronic disease and enhance healthy lifespan through precision-based approaches across medical specialties.

1 investor

AtriAN Medical develops a pulsed field ablation catheter system that targets and disables epicardial ganglionated plexi via a sub-xiphoid approach to treat atrial fibrillation while sparing heart muscle tissue. The company builds cardiac-customized pulsed field generators and IP-protected catheters for cardioneuroablation in cardiac electrophysiology.

1 investor

AtriCure develops medical devices for treating atrial fibrillation and related cardiac conditions, serving electrophysiologists, cardiothoracic surgeons, and thoracic surgeons globally. The company offers ablation systems, left atrial appendage exclusion devices, minimally invasive therapies, and cryoprobes for nerve ablation and pain management in cardiac procedures.

1 investor

Atrility develops cardiac medical devices, including the AtriAmp for post-operative arrhythmia monitoring, aimed at improving care for cardiac patients. The company combines healthcare, business, and engineering expertise to bring medical technology to market.

1 investor